It is well known that COX-2, a rate-limiting enzyme in the biosynthesis of prostaglandins, is overexpressed constitutively in various cancer cells and recognized as one of the hallmarks of chronic inflammation-associated malignancies. The gene discussed is PTGS2; the disease is cancer.